ClinicalTrials.gg
RecruitingNCT07797374BAROSPORUpdated Sep 1, 2026

Postoperative Nausea, Vomiting and Pain After Bariatric Surgery - a National Registry Study

An observational study in Postoperative Nausea and Vomiting, Postoperative Pain and Obesity, Morbid, sponsored by Umeå University. Recruiting at 2 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Umeå University · Observational

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
30,000
Ages
18 Years and older
Sex
All
01

Study summary

Around 4,000-5,000 bariatric (weight-loss) operations are performed in Sweden every year. Nausea, vomiting and pain are common immediately after these operations, cause considerable suffering and increase the intensity and length of hospital care. Bariatric surgery is one of the procedures with the highest risk of postoperative nausea and vomiting (PONV): about one third of patients experience PONV already in the recovery unit, and registry data indicate that around 40% report severe pain at the same stage.

This study links two national quality registries - the Swedish Perioperative Register (SPOR) and the Scandinavian Obesity Surgery Registry (SOReg) - to describe how often adult patients experience nausea, vomiting and pain in the post-anaesthesia care unit after primary bariatric surgery, and to identify patient, anaesthetic and surgical factors associated with these outcomes. The study tests whether total intravenous anaesthesia, the addition of a regional nerve block, and preoperative health-related quality of life are associated with PONV and pain, and whether early PONV or pain is associated with complications, unplanned hospital care or reoperation up to one year after surgery. The results are intended to show how well current evidence on preventing PONV and pain is applied in everyday practice and where care can be improved.

Read the detailed description

BACKGROUND Bariatric surgery is common in Sweden with 4,000-5,000 procedures per year. Data on each operation are recorded in the Swedish Perioperative Register (SPOR), covering more than 90% of all surgical procedures in Sweden with automatic data transfer from hospital IT systems, and in the Scandinavian Obesity Surgery Registry (SOReg), with a coverage of approximately 98% of bariatric surgery. Postoperative nausea and vomiting (PONV) and pain are frequent after bariatric surgery. Evidence-based guidelines exist, but 25-40% of surgical patients still experience PONV, and up to 50% may experience severe postoperative pain. Risk factors are validated at a general level but not specifically for bariatric surgery.

OBJECTIVES

  1. To describe the risk of early PONV and pain in the post-anaesthesia care unit (PACU) after primary bariatric surgery.
  2. To identify factors associated with early PONV and pain.
  3. To test the hypotheses that total intravenous anaesthesia (compared with inhalational anaesthesia) and the addition of a regional block are associated with lower risk of PONV or pain in the PACU; that poorer preoperative health-related quality of life (RAND-36) is associated with higher risk of PONV, pain and severe pain; and that PONV or pain in the PACU is associated with higher risk of postoperative complications up to one year after surgery. Separate hypothesis tests are performed for PONV and pain.

DESIGN Exploratory observational cohort study based on registry data. Patients aged 18 years or older with a primary bariatric procedure registered in SOReg during 2018-2027 are identified. Records are linked to SPOR by Uppsala Clinical Research Center (UCR) using personal identity number and date of surgery (+/- 3 days). If several SPOR records fall within the interval, each is included as a separate row with an index variable linking to the SOReg operation. Each individual is assigned a unique serial number and the dataset delivered to the research group contains pseudonymised data only. Data extractions are made at most once per year from 2025; the first analyses cover 2018-2023.

VARIABLES From SOReg: preoperative data (patient characteristics, comorbidity, laboratory values, preoperative work-up, RAND-36), operative data (procedure type, technique, intraoperative complications) and postoperative follow-up up to one year (complications, hospital care, reoperation). From SPOR: patient characteristics, process data, operative data (diagnosis, procedure, anaesthesia type, times, deviations), postoperative data (pain, nausea/vomiting, deviations, level of care) and date of death.

STATISTICAL ANALYSIS Descriptive statistics with univariable and multivariable analysis of associations. Candidate variables include sex, age, comorbidity, preoperative pain, anaesthesia type, procedure type, surgical technique and length of stay. The expected sample is approximately 70% of all bariatric operations in Sweden, about 3,000 patients per year; the main reason for exclusion is expected to be missing PACU registration of pain and/or nausea at some hospitals. As the study includes more than half of the target population, no formal power calculation is performed.

DATA PROTECTION Only pseudonymised data are handled. Data are stored at Umeå University with access restricted to the study researchers, in accordance with current legislation.

02

Conditions studied

  • Postoperative Nausea and Vomiting
  • Postoperative Pain
  • Obesity, Morbid
  • Bariatric Surgery

Keywords

  • PONV
  • postoperative pain
  • anaesthesia
  • total intravenous anaesthesia
  • regional anaesthesia
  • bariatric surgery
  • quality registry
  • SPOR
  • SOReg
  • RAND-36
03

In context

Postoperative Nausea and Vomiting

638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.

This study's planned enrollment of 30,000 is above the median of 208 across 93 observational studies indexed under Postoperative Nausea and Vomiting.

Browse Postoperative Nausea and Vomiting studies →

Lead sponsor

Umeå University is the lead sponsor of 272 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All adult patients registered in the Scandinavian Obesity Surgery Registry (SOReg) with a primary bariatric procedure during 2018-2027 and a matching operation record in the Swedish Perioperative Register (SPOR).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Primary bariatric surgery registered in SOReg during 2018-2027

Exclusion criteria

Exclusion Criteria:

  • Revision bariatric surgery
  • If more than one bariatric operation is registered for the same patient, only the primary operation is included
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
30,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adults undergoing primary bariatric surgery in Sweden 2018-2027

    Patients aged 18 years or older with a primary bariatric procedure registered in the Scandinavian Obesity Surgery Registry (SOReg) 2018-2027 and a matching operation record in the Swedish Perioperative Register (SPOR).

06

What researchers measure

Primary outcomes

  1. Incidence of postoperative nausea and/or vomiting in the post-anaesthesia care unit

    Number of operations with registered nausea and/or vomiting in the PACU divided by the total number of operations. Source: SPOR variable "Illamående postoperativt" (postoperative nausea).

    Time frame: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)

  2. Pain intensity in the post-anaesthesia care unit, numerical rating scale (NRS) 0-10

    Median NRS score (0 = no pain, 10 = worst imaginable pain). Source: SPOR variables "Smärta inom 1 tim efter ankomst UVA" (pain within 1 hour of PACU arrival) and "Smärta postoperativt, högsta" (highest postoperative pain).

    Time frame: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)

  3. Incidence of severe pain in the post-anaesthesia care unit

    Number of operations with NRS \>= 7 divided by the total number of operations.

    Time frame: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)

Secondary outcomes

  1. Proportion of patients with postoperative complications, unplanned hospital care or reoperation - 6 weeks

    Complications (including Clavien-Dindo grade), unplanned hospital care and reoperation as registered in SOReg at the 6-week follow-up.

    Time frame: Up to 6 weeks after surgery

  2. Proportion of patients with postoperative complications, unplanned hospital care or reoperation - 1 year

    Complications (including Clavien-Dindo grade), unplanned hospital care and reoperation as registered in SOReg at the 1-year follow-up.

    Time frame: Up to 1 year after surgery

07

Study locations

2 of 2 sites recruiting
  • Sundsvall Hospital, Department of Anaesthesia and Intensive Care
    Sundsvall, 851 86, Sweden
    Recruiting
  • Umeå University, Department of Diagnostics and Intervention
    Umeå, 901 87, Sweden
    Recruiting
    • Jakob Walldén, MD, PhD · Contactjakob.wallden@umu.se · +46 60 14 52 55
    • Jakob Walldén, MD, PhD · Principal investigator
    • Magnus Hultin, MD, PhD · Sub investigator
    • Yucel Cengiz, MD, PhD · Sub investigator
    • Antonio Moraitis, MD · Sub investigator
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2025 (actual). Primary completion is estimated for Dec 2027, 26 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2026
First posted
Sep 1, 2026
StartActual
Oct 1, 2025
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 2028
Last update
Sep 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07797374
Lead sponsor
Umeå University
Collaborators
Västernorrland County Council, Sweden, The Scandinavian Obesity Surgery Registry
Responsible party
Jakob Walldén (Associate Professor, Senior Consultant in Anaesthesia and Intensive Care, Umeå University) — Principal investigator
First posted
Sep 1, 2026
Start date
Oct 1, 2025
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 2028 (estimated)
Last update
Sep 1, 2026

Study contacts

Jakob Walldén, MD, PhD
Contact
jakob.wallden@umu.se
+46 60 14 52 55
Jakob Walldén, MD, PhD
principal investigator · Umeå University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion